Bones of contention: Predicting and preventing fractures in patients receiving peritoneal dialysis

Perit Dial Int. 2023 Jun 25:8968608231181264. doi: 10.1177/08968608231181264. Online ahead of print.ABSTRACTLow bone density is common among those individuals receiving peritoneal dialysis. While cross-sectional studies support an association between low bone mineral density (BMD) and prevalent fracture, relying on bone density alone, particularly at the lumbar spine and in those with high degrees of hyperparathyroidism may underestimate fracture risk. Commonly used risk calculators in the general population have been shown to perform reasonably well in those receiving dialysis although they do not include any risk factors for high turnover bone disease that may play a role in increased fracture risk. The best options for decreasing fracture risk in patients receiving peritoneal dialysis are unclear. The evidence for bisphosphonates is limited to small studies of BMD, and concerns about drug accumulation have limited their use. Denosumab is more commonly used and has some evidence for improvement in BMD but carries with it a high risk of hypocalcaemia requiring rigorous prophylaxis. More research is needed to explore practical methods to identify those at risk of fracture and determine the efficacy of antiresorptive and anabolic therapies to decrease this risk.PMID:37357440 | DOI:10.1177/08968608231181264
Source: Peritoneal Dialysis International - Category: Urology & Nephrology Authors: Source Type: research